Physician profile
Ryan A Pitts
NPI 1356314603
$830.93
in general payments reported to CMS, 2019-2025
17 companies · $30.42 in 2025
The $30.42 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2021: $558 · 2022: $55.97 · 2023: $45.03 · 2025: $30.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $209.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.69 | 2021 | |
| Amgen INC. | $69.21 | 2019-2023 | Otezla, Repatha |
| Supernus Pharmaceuticals, INC. | $56.12 | 2019 | |
| Lilly USA, LLC | $43.85 | 2021-2023 | Emgality, Jardiance |
| Astrazeneca Pharmaceuticals LP | $43.76 | 2021 | |
| Abbvie INC. | $39.24 | 2021 | |
| Glaxosmithkline, LLC. | $26.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.04 | 2022 | |
| Medtronic USA, INC. | $19.80 | 2019 | |
| Mannkind Corporation | $18.57 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.36 | 2022 | |
| Alk-Abello, INC | $16.87 | 2023 | Odactra, Ragwitek, Grastek |
| Vertex Pharmaceuticals Incorporated | $15.43 | 2025 | |
| Ani Pharmaceuticals, INC. | $14.99 | 2025 | Purified Cortrophin Gel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.